Literature DB >> 25049087

Cochlin in normal middle ear and abnormal middle ear deposits in DFNA9 and Coch (G88E/G88E) mice.

Nahid G Robertson1, Jennifer T O'Malley, Cheng Ai Ong, Anne B S Giersch, Jun Shen, Konstantina M Stankovic, Cynthia C Morton.   

Abstract

DFNA9 sensorineural hearing loss and vestibular disorder, caused by mutations in COCH, has a unique identifying histopathology including prominent acellular deposits in cochlear and vestibular labyrinths. A recent study has shown presence of deposits also in middle ear structures of DFNA9-affected individuals (McCall et al., J Assoc Res Otolaryngol 12:141-149, 2004). To investigate the possible role of cochlin in the middle ear and in relation to aggregate formation, we evaluated middle ear histopathology in our Coch knock-in (Coch (G88E/G88E) ) mouse model, which harbors one of the DFNA9-causative mutations. Our findings reveal accumulation of acellular deposits in the incudomalleal and incudostapedial joints in Coch (G88E/G88E) mice, similar to those found in human DFNA9-affected temporal bones. Aggregates are absent in negative control Coch (+/+) and Coch (-/-) mice. Thickening of the tympanic membrane (TM) found in humans with DFNA9 was not appreciably detected in Coch (G88E/G88E) mice at the evaluated age. We investigated cochlin localization first in the Coch (+/+)mouse and in normal human middle ears, and found prominent and specific cochlin staining in the incudomalleal joint, incudostapedial joint, and the pars tensa of the TM, which are the three sites where abnormal deposits are detected in DFNA9-affected middle ears. Cochlin immunostaining of Coch (G88E/G88E) and DFNA9-affected middle ears showed mutant cochlin localization within areas of aggregates. Cochlin staining was heterogeneous throughout DFNA9 middle ear deposits, which appear as unorganized and overlapping mixtures of both eosinophilic and basophilic substances. Immunostaining for type II collagen colocalized with cochlin in pars tensa of the tympanic membrane. In contrast, immunostaining for type II collagen did not overlap with cochlin in interossicular joints, where type II collagen was localized in the region of the chondrocytes, but not in the thin layer of the articular surface of the ossicles nor in the eosinophilic deposits with specific cochlin staining.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25049087      PMCID: PMC4389958          DOI: 10.1007/s10162-014-0481-9

Source DB:  PubMed          Journal:  J Assoc Res Otolaryngol        ISSN: 1438-7573


  41 in total

1.  Identification of the protein product of the Coch gene (hereditary deafness gene) as the major component of bovine inner ear protein.

Authors:  T Ikezono; A Omori; S Ichinose; R Pawankar; A Watanabe; T Yagi
Journal:  Biochim Biophys Acta       Date:  2001-03-26

Review 2.  The superfamily of proteins with von Willebrand factor type A-like domains: one theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms.

Authors:  A Colombatti; P Bonaldo
Journal:  Blood       Date:  1991-06-01       Impact factor: 22.113

3.  Type II collagen distribution in rodents.

Authors:  T J Yoo; K Tomoda
Journal:  Laryngoscope       Date:  1988-11       Impact factor: 3.325

4.  Crystal structure of the A domain from the alpha subunit of integrin CR3 (CD11b/CD18).

Authors:  J O Lee; P Rieu; M A Arnaout; R Liddington
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

5.  NMR structure of the LCCL domain and implications for DFNA9 deafness disorder.

Authors:  E Liepinsh; M Trexler; A Kaikkonen; J Weigelt; L Bányai; L Patthy; G Otting
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

6.  Limulus factor C. An endotoxin-sensitive serine protease zymogen with a mosaic structure of complement-like, epidermal growth factor-like, and lectin-like domains.

Authors:  T Muta; T Miyata; Y Misumi; F Tokunaga; T Nakamura; Y Toh; Y Ikehara; S Iwanaga
Journal:  J Biol Chem       Date:  1991-04-05       Impact factor: 5.157

7.  Tumor necrosis factor during experimental lipopolysaccharide-induced otitis media.

Authors:  T F DeMaria; D M Murwin
Journal:  Laryngoscope       Date:  1997-03       Impact factor: 3.325

Review 8.  Autosomal dominant sensorineural hearing loss. Pedigrees, audiologic findings, and temporal bone findings in two kindreds.

Authors:  U Khetarpal; H F Schuknecht; R R Gacek; L B Holmes
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1991-09

9.  Isolation of novel and known genes from a human fetal cochlear cDNA library using subtractive hybridization and differential screening.

Authors:  N G Robertson; U Khetarpal; G A Gutiérrez-Espeleta; F R Bieber; C C Morton
Journal:  Genomics       Date:  1994-09-01       Impact factor: 5.736

10.  Localization of type II, IX and V collagen in the inner ear.

Authors:  N B Slepecky; J E Savage; T J Yoo
Journal:  Acta Otolaryngol       Date:  1992       Impact factor: 1.494

View more
  5 in total

Review 1.  Immunohistochemical techniques for the human inner ear.

Authors:  Ivan A Lopez; Gail Ishiyama; Seiji Hosokawa; Kumiko Hosokawa; Dora Acuna; Fred H Linthicum; Akira Ishiyama
Journal:  Histochem Cell Biol       Date:  2016-08-01       Impact factor: 4.304

2.  Histopathology of the Human Inner Ear in the p.L114P COCH Mutation (DFNA9).

Authors:  Barbara J Burgess; Jennifer T O'Malley; Takefumi Kamakura; Kris Kristiansen; Nahid G Robertson; Cynthia C Morton; Joseph B Nadol
Journal:  Audiol Neurootol       Date:  2016-03-30       Impact factor: 1.854

3.  Cochlin Deficiency Protects Against Noise-Induced Hearing Loss.

Authors:  Richard Seist; Lukas D Landegger; Nahid G Robertson; Sasa Vasilijic; Cynthia C Morton; Konstantina M Stankovic
Journal:  Front Mol Neurosci       Date:  2021-05-24       Impact factor: 5.639

4.  Cochlin Deficiency Protects Aged Mice from Noise-Induced Hearing Loss.

Authors:  Dorien Verdoodt; Noa Peeleman; Krystyna Szewczyk; Guy Van Camp; Peter Ponsaerts; Vincent Van Rompaey
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

5.  Involvement of cochlin binding to sulfated heparan sulfate/heparin in the pathophysiology of autosomal dominant late-onset hearing loss (DFNA9).

Authors:  Tomoko Honda; Norihito Kawasaki; Rei Yanagihara; Ryo Tamura; Karin Murakami; Tomomi Ichimiya; Naoki Matsumoto; Shoko Nishihara; Kazuo Yamamoto
Journal:  PLoS One       Date:  2022-07-28       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.